Compare companies

Pick 2–4 companies for a side-by-side spec sheet.

Selected: 1 / 4

Side by side

FieldTruveta
Categories
drug-discoveryhealthcare
HQSeattle, Washington
Founded2023
Latest valuation~$1B+ (estimated post-Series C)
Annual Recurring Revenue (ARR)—
Funding to date$320M+
Headcount~100-150 (estimated)
Profitability—
Statusactive
Pricing tierenterprise
DescriptionBuilds the world's largest and most diverse database of genotypic and phenotypic patient information to accelerate drug discovery and precision medicine. Aggregates real-world clinical and genomic data from healthcare providers to train AI models for patient stratification, biomarker discovery, and clinical trial recruitment.